{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:58:51Z","timestamp":1773809931423,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"DOI":"10.7759\/cureus.27290","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T16:27:07Z","timestamp":1658852827000},"source":"Crossref","is-referenced-by-count":5,"title":["The Business of T Cell Subsets and Cytokines in the Immunopathogenesis of Inflammatory Bowel Disease"],"prefix":"10.7759","author":[{"given":"Shreekant","family":"Bharti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mridushri","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1443-9573.2005.00191.x","article-title":"Inflammatory bowel disease pathogenesis: therapeutic implications","volume":"6","author":"Fiocchi C","year":"2005","unstructured":"Fiocchi C. Inflammatory bowel disease pathogenesis: therapeutic implications. Chin J Dig Dis. 2005, 6:6-9. 10.1111\/j.1443-9573.2005.00191.x","journal-title":"Chin J Dig Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Seminar Crohn\u2019s disease","volume":"380","author":"Baumgart DC","year":"2012","unstructured":"Baumgart DC, Sandborn WJ. Seminar Crohn\u2019s disease. Lancet. 2012, 380:1590-605. 10.1016\/S0140-6736(12)60026-9","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.05.013","article-title":"Inflammatory bowel disease as a model for translating the microbiome","volume":"40","author":"Huttenhower C","year":"2014","unstructured":"Huttenhower C, Kostic AD, Xavier RJ. Inflammatory bowel disease as a model for translating the microbiome. Immunity. 2014, 40:843-54. 10.1016\/j.immuni.2014.05.013","journal-title":"Immunity"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000714","article-title":"Cytokine networks and T-cell subsets in inflammatory bowel diseases","volume":"22","author":"Chen ML","year":"2016","unstructured":"Chen ML, Sundrud MS. Cytokine networks and T-cell subsets in inflammatory bowel diseases. Inflamm Bowel Dis. 2016, 22:1157-67. 10.1097\/MIB.0000000000000714","journal-title":"Inflamm Bowel Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00551","article-title":"Inflammatory bowel disease: genetics, epigenetics, and pathogenesis","volume":"6","author":"Loddo I","year":"2015","unstructured":"Loddo I, Romano C. Inflammatory bowel disease: genetics, epigenetics, and pathogenesis. Front Immunol. 2015, 6:551. 10.3389\/fimmu.2015.00551","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nature22969","article-title":"Fine-mapping inflammatory bowel disease loci to single-variant resolution","volume":"547","author":"Huang H","year":"2017","unstructured":"Huang H, Fang M, Jostins L, et al.. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature. 2017, 547:173-8. 10.1038\/nature22969","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.01.003","article-title":"SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease","volume":"8","author":"Fowler SA","year":"2014","unstructured":"Fowler SA, Ananthakrishnan AN, Gardet A, et al.. SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease. J Crohns Colitis. 2014, 8:845-51. 10.1016\/j.crohns.2014.01.003","journal-title":"J Crohns Colitis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093379","article-title":"Interplay between cytokine circuitry and transcriptional regulation shaping helper T cell pathogenicity and plasticity in inflammatory bowel disease","volume":"21","author":"Fu SH","year":"2020","unstructured":"Fu SH, Chien MW, Hsu CY, Liu YW, Sytwu HK. Interplay between cytokine circuitry and transcriptional regulation shaping helper T cell pathogenicity and plasticity in inflammatory bowel disease. Int J Mol Sci. 2020, 21:10.3390\/ijms21093379","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010110","article-title":"Dissecting the heterogeneity in T-cell mediated inflammation in IBD","volume":"9","author":"Tindemans I","year":"2020","unstructured":"Tindemans I, Joosse ME, Samsom JN. Dissecting the heterogeneity in T-cell mediated inflammation in IBD. Cells. 2020, 9:110. 10.3390\/cells9010110","journal-title":"Cells"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12053","article-title":"Genetics of inflammatory bowel diseases: a comparison between western and eastern perspectives","volume":"28","author":"Cheon JH","year":"2013","unstructured":"Cheon JH. Genetics of inflammatory bowel diseases: a comparison between western and eastern perspectives. J Gastroenterol Hepatol. 2013, 28:220-6. 10.1111\/jgh.12053","journal-title":"J Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00605","article-title":"Regulatory T cell and forkhead box protein 3 as modulators of immune homeostasis","volume":"8","author":"Pereira LM","year":"2017","unstructured":"Pereira LM, Gomes ST, Ishak R, Vallinoto AC. Regulatory T cell and forkhead box protein 3 as modulators of immune homeostasis. Front Immunol. 2017, 8:605. 10.3389\/fimmu.2017.00605","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2018.16.1.26","article-title":"Immunological pathogenesis of inflammatory bowel disease","volume":"16","author":"Lee SH","year":"2018","unstructured":"Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018, 16:26-42. 10.5217\/ir.2018.16.1.26","journal-title":"Intest Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0331","article-title":"Inflammatory bowel disease in childhood and adolescence","volume":"114","author":"D\u00e4britz J","year":"2017","unstructured":"D\u00e4britz J, Gerner P, Enninger A, Cla\u00dfen M, Radke M. Inflammatory bowel disease in childhood and adolescence. Dtsch Arztebl Int. 2017, 114:331-8. 10.3238\/arztebl.2017.0331","journal-title":"Dtsch Arztebl Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.04.008","article-title":"Homeostatic immunity and the microbiota","volume":"46","author":"Belkaid Y","year":"2017","unstructured":"Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017, 46:562-76. 10.1016\/j.immuni.2017.04.008","journal-title":"Immunity"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjt026","article-title":"Phenotypic and functional characteristic of a newly identified CD8+ FOXP3-CD103+ regulatory T cells","volume":"6","author":"Liu Y","year":"2014","unstructured":"Liu Y, Lan Q, Lu L, et al.. Phenotypic and functional characteristic of a newly identified CD8+ FOXP3-CD103+ regulatory T cells. J Mol Cell Biol. 2014, 6:81-92. 10.1093\/jmcb\/mjt026","journal-title":"J Mol Cell Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13037","article-title":"Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells","volume":"156","author":"Sprouse ML","year":"2019","unstructured":"Sprouse ML, Bates NA, Felix KM, Wu HJ. Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells. Immunology. 2019, 156:305-18. 10.1111\/imm.13037","journal-title":"Immunology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.08.005","article-title":"Increased intestinal permeability is associated with later development of Crohn\u2019s disease","volume":"159","author":"Turpin W","year":"2020","unstructured":"Turpin W, Lee SH, Raygoza Garay JA, et al.. Increased intestinal permeability is associated with later development of Crohn\u2019s disease. Gastroenterology. 2020, 159:2092-2100.e5. 10.1053\/j.gastro.2020.08.005","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.182170","article-title":"Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease","volume":"58","author":"Rovedatti L","year":"2009","unstructured":"Rovedatti L, Kudo T, Biancheri P, et al.. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut. 2009, 58:1629-36. 10.1136\/gut.2009.182170","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i7.2195","article-title":"Role of regulatory T cell in the pathogenesis of inflammatory bowel disease","volume":"22","author":"Yamada A","year":"2016","unstructured":"Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2016, 22:2195-205. 10.3748\/wjg.v22.i7.2195","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21316","article-title":"Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing","volume":"17","author":"Krishnan K","year":"2011","unstructured":"Krishnan K, Arnone B, Buchman A. Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing. Inflamm Bowel Dis. 2011, 17:410-22. 10.1002\/ibd.21316","journal-title":"Inflamm Bowel Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor B","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011, 474:307-17. 10.1038\/nature10209","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.04.004","article-title":"Inflammatory bowel disease","volume":"161","author":"Corridoni D","year":"2014","unstructured":"Corridoni D, Arseneau KO, Cominelli F. Inflammatory bowel disease. Immunol Lett. 2014, 161:231-5. 10.1016\/j.imlet.2014.04.004","journal-title":"Immunol Lett"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2403","article-title":"The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models","volume":"8","author":"Nell S","year":"2010","unstructured":"Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol. 2010, 8:564-77. 10.1038\/nrmicro2403","journal-title":"Nat Rev Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins L","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, et al.. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012, 491:119-24. 10.1038\/nature11582","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.07.017","article-title":"IL-12-and IL-23 in health and disease","volume":"25","author":"Croxford AL","year":"2014","unstructured":"Croxford AL, Kulig P, Becher B. IL-12-and IL-23 in health and disease. 2014, 25:415-421. 10.1016\/j.cytogfr.2014.07.017"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.01.014","article-title":"Helper T cell diversity and plasticity","volume":"24","author":"Nakayamada S","year":"2012","unstructured":"Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr Opin Immunol. 2012, 24:297-302. 10.1016\/j.coi.2012.01.014","journal-title":"Curr Opin Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group","volume":"337","author":"Targan SR","year":"1997","unstructured":"Targan SR, Hanauer SB, van Deventer SJ, et al.. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group. N Engl J Med. 1997, 337:1029-35. 10.1056\/NEJM199710093371502","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/382171a0","article-title":"Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells","volume":"382","author":"Thierfelder WE","year":"1996","unstructured":"Thierfelder WE, van Deursen JM, Yamamoto K, et al.. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 1996, 382:171-4. 10.1038\/382171a0","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.6.3702","article-title":"Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype","volume":"162","author":"Claesson MH","year":"1999","unstructured":"Claesson MH, Bregenholt S, Bonhagen K, et al.. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol. 1999, 162:3702-10.","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma--present in most, absent in many","volume":"15","author":"Fahy JV","year":"2015","unstructured":"Fahy JV. Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol. 2015, 15:57-65. 10.1038\/nri3786","journal-title":"Nat Rev Immunol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution","volume":"129","author":"Heller F","year":"2005","unstructured":"Heller F, Florian P, Bojarski C, et al.. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005, 129:550-64. 10.1016\/j.gastro.2005.05.002","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130318","article-title":"The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin","volume":"8","author":"Weaver CT","year":"2013","unstructured":"Weaver CT, Elson CO, Fouser LA, Kolls JK. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol. 2013, 8:477-512. 10.1146\/annurev-pathol-011110-130318","journal-title":"Annu Rev Pathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung Y","year":"2009","unstructured":"Chung Y, Chang SH, Martinez GJ, et al.. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity. 2009, 30:576-87. 10.1016\/j.immuni.2009.02.007","journal-title":"Immunity"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence A","year":"2007","unstructured":"Laurence A, Tato CM, Davidson TS, et al.. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007, 26:371-81. 10.1016\/j.immuni.2007.02.009","journal-title":"Immunity"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling","volume":"467","author":"Ghoreschi K","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang XP, et al.. Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling. Nature. 2010, 467:967-71. 10.1038\/nature09447","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22348","article-title":"T helper cells plasticity in inflammation","volume":"85","author":"Cosmi L","year":"2014","unstructured":"Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F. T helper cells plasticity in inflammation. Cytometry A. 2014, 85:36-42. 10.1002\/cyto.a.22348","journal-title":"Cytometry A"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061099","article-title":"Interleukin-23 drives innate and T cell-mediated intestinal inflammation","volume":"203","author":"Hue S","year":"2006","unstructured":"Hue S, Ahern P, Buonocore S, et al.. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006, 203:2473-83. 10.1084\/jem.20061099","journal-title":"J Exp Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.10","article-title":"FOXP3+ regulatory T cells and their functional regulation","volume":"12","author":"Li Z","year":"2015","unstructured":"Li Z, Li D, Tsun A, Li B. FOXP3+ regulatory T cells and their functional regulation. Cell Mol Immunol. 2015, 12:558-65. 10.1038\/cmi.2015.10","journal-title":"Cell Mol Immunol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin RS","year":"2001","unstructured":"Wildin RS, Ramsdell F, Peake J, et al.. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001, 27:18-20. 10.1038\/83707","journal-title":"Nat Genet"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-97","article-title":"Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation","volume":"12","author":"Boehm F","year":"2012","unstructured":"Boehm F, Martin M, Kesselring R, Schiechl G, Geissler EK, Schlitt HJ, Fichtner-Feigl S. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. BMC Gastroenterol. 2012, 12:97. 10.1186\/1471-230X-12-97","journal-title":"BMC Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli LA","year":"2015","unstructured":"Monticelli LA, Osborne LC, Noti M, Tran SV, Zaiss DM, Artis D. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc Natl Acad Sci U S A. 2015, 112:10762-7. 10.1073\/pnas.1509070112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.217117","article-title":"Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNF\u03b1 treatment","volume":"60","author":"Veltkamp C","year":"2011","unstructured":"Veltkamp C, Anstaett M, Wahl K, et al.. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNF\u03b1 treatment. Gut. 2011, 60:1345-53. 10.1136\/gut.2010.217117","journal-title":"Gut"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-009-9345-1","article-title":"Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease","volume":"30","author":"Eastaff-Leung N","year":"2010","unstructured":"Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010, 30:80-9. 10.1007\/s10875-009-9345-1","journal-title":"J Clin Immunol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz SZ","year":"2012","unstructured":"Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012, 30:531-64. 10.1146\/annurev.immunol.25.022106.141623","journal-title":"Annu Rev Immunol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-075053","article-title":"Innate lymphoid cells: emerging insights in development, lineage relationships, and function","volume":"30","author":"Spits H","year":"2012","unstructured":"Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012, 30:647-75. 10.1146\/annurev-immunol-020711-075053","journal-title":"Annu Rev Immunol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore S","year":"2010","unstructured":"Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010, 464:1371-5. 10.1038\/nature08949","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101712","article-title":"IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease","volume":"208","author":"Geremia A","year":"2011","unstructured":"Geremia A, Arancibia-C\u00e1rcamo CV, Fleming MP, et al.. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med. 2011, 208:1127-33. 10.1084\/jem.20101712","journal-title":"J Exp Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells","volume":"38","author":"Fuchs A","year":"2013","unstructured":"Fuchs A, Vermi W, Lee JS, et al.. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells. Immunity. 2013, 38:769-81. 10.1016\/j.immuni.2013.02.010","journal-title":"Immunity"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081847","article-title":"Translating treg therapy for inflammatory bowel disease in humanized mice","volume":"10","author":"Negi S","year":"2021","unstructured":"Negi S, Saini S, Tandel N, Sahu K, Mishra RP, Tyagi RK. Translating treg therapy for inflammatory bowel disease in humanized mice. Cells. 2021, 10:1847. 10.3390\/cells10081847","journal-title":"Cells"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93304-the-business-of-t-cell-subsets-and-cytokines-in-the-immunopathogenesis-of-inflammatory-bowel-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:35Z","timestamp":1707507335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93304-the-business-of-t-cell-subsets-and-cytokines-in-the-immunopathogenesis-of-inflammatory-bowel-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.27290","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,26]]}}}